The rate of lymph node metastasis was also noted to be higher in patients with N-RAS mutations (75%) compared to B-RAF mutant and WT patients (46% and 61%, respectively) (P = 0.01). This evidence concerns the gene NRAS and metastatic malignant neoplasm in the lymph nodes.